ZA200005695B - Process for the preparation of piperidinylaminome thyltrifluoromethyl cyclic ether compounds. - Google Patents

Process for the preparation of piperidinylaminome thyltrifluoromethyl cyclic ether compounds.

Info

Publication number
ZA200005695B
ZA200005695B ZA200005695A ZA200005695A ZA200005695B ZA 200005695 B ZA200005695 B ZA 200005695B ZA 200005695 A ZA200005695 A ZA 200005695A ZA 200005695 A ZA200005695 A ZA 200005695A ZA 200005695 B ZA200005695 B ZA 200005695B
Authority
ZA
South Africa
Prior art keywords
thyltrifluoromethyl
piperidinylaminome
preparation
cyclic ether
ether compounds
Prior art date
Application number
ZA200005695A
Other languages
English (en)
Inventor
Stephane Caron
Enrique Vazquez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200005695B publication Critical patent/ZA200005695B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200005695A 1999-10-18 2000-10-16 Process for the preparation of piperidinylaminome thyltrifluoromethyl cyclic ether compounds. ZA200005695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16022699P 1999-10-18 1999-10-18

Publications (1)

Publication Number Publication Date
ZA200005695B true ZA200005695B (en) 2002-04-16

Family

ID=22576040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005695A ZA200005695B (en) 1999-10-18 2000-10-16 Process for the preparation of piperidinylaminome thyltrifluoromethyl cyclic ether compounds.

Country Status (24)

Country Link
US (2) US6486325B1 (cs)
EP (1) EP1095939B1 (cs)
JP (1) JP3564685B2 (cs)
KR (1) KR100459952B1 (cs)
CN (1) CN1293193A (cs)
AR (1) AR026053A1 (cs)
AT (1) ATE257477T1 (cs)
AU (1) AU784275B2 (cs)
BR (1) BR0004901A (cs)
CA (1) CA2323315C (cs)
CZ (1) CZ299029B6 (cs)
DE (1) DE60007599T2 (cs)
DK (1) DK1095939T3 (cs)
ES (1) ES2211455T3 (cs)
HU (1) HUP0004061A2 (cs)
ID (1) ID27627A (cs)
IL (1) IL139012A (cs)
IN (1) IN190078B (cs)
PL (1) PL343290A1 (cs)
PT (1) PT1095939E (cs)
RU (1) RU2184116C1 (cs)
TR (1) TR200003002A2 (cs)
YU (1) YU60600A (cs)
ZA (1) ZA200005695B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
KR20040064687A (ko) * 2001-12-21 2004-07-19 도오레 화인케미칼 가부시키가이샤 광학 활성 시스 피페리딘 유도체의 제조법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
JPH0794440B2 (ja) * 1991-03-26 1995-10-11 フアイザー・インコーポレイテツド 置換ピペリジンの立体選択的製造
US5294744A (en) * 1993-04-20 1994-03-15 Pfizer Inc. Formylation process for aromatic aldehydes
KR19980703354A (ko) * 1995-03-27 1998-10-15 나카토미히로타카 피페리딘 유도체
DE69612003T2 (de) * 1995-07-07 2001-06-21 Pfizer Inc., New York Substituierte benzolaktamverbindungen als substanz-p-antagonisten
TW340842B (en) * 1995-08-24 1998-09-21 Pfizer Substituted benzylaminopiperidine compounds
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
AU775861B2 (en) * 1999-05-21 2004-08-19 Pfizer Products Inc. 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives

Also Published As

Publication number Publication date
EP1095939A2 (en) 2001-05-02
AR026053A1 (es) 2002-12-26
ID27627A (id) 2001-04-19
US20030236268A1 (en) 2003-12-25
DE60007599T2 (de) 2004-11-11
AU6547400A (en) 2001-04-26
PT1095939E (pt) 2004-04-30
KR20010051069A (ko) 2001-06-25
CZ20003840A3 (cs) 2002-02-13
ES2211455T3 (es) 2004-07-16
EP1095939A3 (en) 2001-05-23
KR100459952B1 (ko) 2004-12-04
JP3564685B2 (ja) 2004-09-15
US6486325B1 (en) 2002-11-26
BR0004901A (pt) 2001-05-29
CN1293193A (zh) 2001-05-02
JP2001151773A (ja) 2001-06-05
EP1095939B1 (en) 2004-01-07
IL139012A0 (en) 2001-11-25
ATE257477T1 (de) 2004-01-15
YU60600A (sh) 2002-12-10
CA2323315C (en) 2008-07-29
TR200003002A2 (tr) 2001-05-21
DK1095939T3 (da) 2004-04-13
HU0004061D0 (en) 2000-12-28
IL139012A (en) 2007-06-17
HUP0004061A2 (hu) 2002-05-29
AU784275B2 (en) 2006-03-02
RU2184116C1 (ru) 2002-06-27
IN190078B (cs) 2003-06-07
CZ299029B6 (cs) 2008-04-09
DE60007599D1 (de) 2004-02-12
CA2323315A1 (en) 2001-04-18
PL343290A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
ZA200108855B (en) Method for the preparation of citalopram.
ZA200108854B (en) Method for the preparation of citalopram.
ZA200110179B (en) Process for the preparation of pure citalopram.
HUP0103291A3 (en) Process for the preparation of citalopram
GB0105981D0 (en) Process for the preparation of pure citalopram
MXPA03001800A (es) Proceso para la preparacion de fenilacetonitrilos sustituidos.
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
AU8824201A (en) Process for the preparation of dinapsoline
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
ZA200108392B (en) Process for the preparation of substituted pyrimidines.
GB2343892B (en) Process for the preparation of d,l-menthol
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
ZA200005695B (en) Process for the preparation of piperidinylaminome thyltrifluoromethyl cyclic ether compounds.
HUP0204189A3 (en) Process for the preparation of diphenyl ether compounds
ZA200101529B (en) Process for the preparation of isoindoline.
SG95675A1 (en) Process for the preparation of 2,6-xylenol
ZA200000578B (en) Process for the preparation of organic azides.
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
HUP0301672A3 (en) Process for the preparation of pesticidal compounds